Workflow
CT和DR球管零组件
icon
Search documents
斯瑞新材(688102):高导高强铜合金领先者 火箭/半导体/医疗等新兴下游打开成长空间
Xin Lang Cai Jing· 2025-12-05 08:29
公司业务:公司是国内领先的材料研发制造企业,核心业务/产品包括高强高导铜合金材料及制品、中 高压电接触材料及制品、高性能金属铬粉、CT 和 DR 球管零组件、光模块芯片基座/壳体、液体火箭发 动机推力室内壁等。通过围绕标杆客户开展销售活动,公司为GE 集团、Wabtec 集团、阿尔斯通等客户 提供非标个性化定制的产品。 从盈利能力看,2025Q1-Q3 公司的销售毛利率为24.04%(+1.04pcts),销售净利率为9.58% (+1.36pcts);期间费用率为12.88%(-0.54pct),其中,销售费用率为1.59%(-0.05pct),管理费用 率为4.91%(-0.18pct),研发费用率为5.67%(+0.42pct),总财务费用较上年同期减少39.05%。 此外,2025Q1-Q3 公司应收账款金额为4.12 亿元、较期初增长43.96%,存货为3.51 亿元、较期初增长 35.79%,合同负债为493.66 亿元、较期初增减少-49.05%。公司备产备货节奏良好,全年业绩稳中向 好。 积极拓展各新兴下游领域,为公司未来成长打开空间在关键项目投资与产能打造上,公司凭借领先的科 研能力与资金实 ...
斯瑞新材(688102):25Q3业绩显著增长,商业航天、医疗影像放量增长
Western Securities· 2025-11-06 09:11
Investment Rating - The report maintains a "Buy" rating for the company [4][10] Core Insights - The company reported significant growth in its Q3 2025 performance, with revenue reaching 1.174 billion yuan, a year-on-year increase of 21.74%, and a net profit attributable to shareholders of 108 million yuan, up 37.74% year-on-year [1][4] - The company is accelerating its industrial layout to meet the rapid growth demands in various niche markets, including commercial aerospace and medical imaging [2] - The company has made important breakthroughs in high-voltage contact materials and is advancing projects to support the domestic medical imaging equipment industry [2] Financial Performance Summary - For the first three quarters of 2025, the company's revenue was 1.174 billion yuan, with a gross margin of 24.04% and a net margin of 9.58% [1][4] - The Q3 2025 revenue was 402 million yuan, representing an 18.08% year-on-year growth, while the net profit for the quarter was 33.07 million yuan, up 48.07% year-on-year [1] - The company expects EPS for 2025 to be 0.20 yuan, with projected PE ratios of 93.2, 67.4, and 53.9 for 2025, 2026, and 2027 respectively [2][3]
斯瑞新材股价涨5.25%,易米基金旗下1只基金重仓,持有13.2万股浮盈赚取11.75万元
Xin Lang Cai Jing· 2025-10-21 02:01
Group 1 - The core point of the news is the performance and market position of Srey New Materials, which saw a stock price increase of 5.25% to 17.85 CNY per share, with a total market capitalization of 13.802 billion CNY [1] - Srey New Materials specializes in high-strength and high-conductivity copper alloy materials, medium and high-voltage electrical contact materials, high-performance metal chromium powder, and components for CT and DR tubes, among others [1] - The revenue composition of Srey New Materials includes high-strength and high-conductivity copper alloy materials and products at 46.51%, medium and high-voltage electrical contact materials and products at 22.90%, and other segments contributing to the remaining revenue [1] Group 2 - According to data, Yimi Fund has a significant holding in Srey New Materials, with the Yimi Kaitai Mixed A Fund holding 132,000 shares, representing 4.1% of the fund's net value, ranking as the tenth largest holding [2] - The Yimi Kaitai Mixed A Fund has a total scale of 34.8855 million CNY and has achieved a year-to-date return of 22.32%, ranking 3690 out of 8162 in its category [2] - The fund manager, He Wenqi, has been in position for nearly 3 years, with the best fund return during his tenure being 35.56% [3]
斯瑞新材6亿定增落地资金实力提升 IPO项目收益7511万年内股价涨107%
Chang Jiang Shang Bao· 2025-10-10 01:37
Core Viewpoint - Srey New Materials (688102.SH) has successfully completed its first private placement after going public, raising approximately 600 million yuan to enhance its financial strength and production capacity in the rapidly developing electronic power and aerospace industries [2][3][5]. Group 1: Fundraising Details - The company issued 41.72 million shares at a price of 14.38 yuan per share, raising a total of 600 million yuan, with a net amount of approximately 590 million yuan after deducting related expenses [2][3]. - The private placement involved 16 specific investors, including 8 individual investors, with the largest single subscription from Zhang Liang, who acquired 6.95 million shares for about 100 million yuan [3][4]. Group 2: Financial Performance - In the first half of 2025, Srey New Materials reported revenue of 772 million yuan, a year-on-year increase of 23.74%, and a net profit of 74.73 million yuan, up 33.61% [2][5][6]. - The company has achieved continuous performance growth since its IPO in 2022, with a cumulative profit distribution of 167 million yuan over three and a half years [4][5]. Group 3: Project Investments - The raised funds will be allocated to the construction of the Srey New Materials Technology Industrial Park and the industrialization of liquid rocket engine thrust chamber materials and components, with a total investment of 230 million yuan for the latter project [5][6]. - The medical imaging equipment project has a total investment of 400 million yuan, with an expected annual revenue of 507 million yuan upon reaching full production [6][7]. Group 4: Market Performance - As of October 9, 2025, Srey New Materials' stock price was 18.25 yuan per share, reflecting a 4.05% increase on that day and a cumulative increase of 106.9% since the beginning of the year [2][5].
斯瑞新材: 陕西斯瑞新材料股份有限公司2024年度向特定对象发行A股股票募集说明书(注册稿)
Zheng Quan Zhi Xing· 2025-09-03 10:16
Group 1 - The company, Shaanxi Sirui Advanced Materials Co., Ltd., is planning to issue A-shares to specific investors in 2024, having received approval from the Shanghai Stock Exchange and the China Securities Regulatory Commission [2][3][4] - The total number of shares to be issued will not exceed 30% of the company's total share capital prior to the issuance, amounting to a maximum of 218,201,367 shares [3][4][5] - The funds raised will be allocated to projects including the industrialization of liquid rocket engine thrust chambers and the production of medical imaging equipment, with a total investment of 69 million yuan and 60 million yuan respectively [5][6] Group 2 - The company has established a research and development team led by nine core technical personnel, collaborating with institutions like Xi'an Jiaotong University and the Chinese Academy of Sciences [9] - The company has faced challenges in maintaining its competitive edge due to rapid technological advancements in the new materials industry, necessitating continuous R&D investment [8][9] - The company’s export revenue has been impacted by tariffs imposed by the United States, with a significant portion of its sales being subject to additional tariffs [10][11] Group 3 - The company has a significant reliance on copper as a primary raw material, making it vulnerable to fluctuations in copper prices, which could adversely affect production costs [14] - The company has experienced a rise in accounts receivable, which poses a risk of cash flow issues if customers face financial difficulties [17] - The company’s financial structure is heavily dependent on debt financing, which could lead to solvency risks if operational challenges arise [16]
斯瑞新材: 国泰海通证券股份有限公司关于陕西斯瑞新材料股份有限公司2024年度持续督导年度跟踪报告
Zheng Quan Zhi Xing· 2025-05-21 11:38
Core Viewpoint - The report outlines the continuous sponsorship and supervision activities conducted by Guotai Junan Securities for Shaanxi Sry New Materials Co., Ltd. following its IPO, emphasizing compliance with regulations and the company's operational performance. Group 1: Continuous Supervision Activities - The company issued 40.01 million shares at a price of RMB 10.48 per share, raising a total of RMB 419.30 million, with a net amount of RMB 356.91 million after deducting issuance costs [1]. - Guotai Junan Securities has been appointed as the continuous sponsor from March 16, 2022, to December 31, 2025, conducting regular communications, site inspections, and due diligence [1][2]. - The sponsor has assisted the company in establishing internal systems and decision-making processes to comply with legal and regulatory requirements [1][2]. Group 2: Information Disclosure and Compliance - The sponsor reviewed the company's information disclosure documents, ensuring compliance with relevant regulations and confirming that disclosures were accurate and timely [9]. - During the supervision period, the company and its major stakeholders did not fail to fulfill any commitments [2][6]. - The company has been advised to maintain transparency and avoid concealing important information [1][2]. Group 3: Financial Performance and Key Indicators - The company's revenue for 2024 is reported at approximately RMB 1.33 billion, reflecting a 12.73% increase from the previous year [20]. - The net profit attributable to shareholders increased by 26.88%, driven by revenue growth and improved sales structure [22]. - The company's total assets reached approximately RMB 2.13 billion, marking a 24.39% increase compared to the previous year [20]. Group 4: Research and Development - The company invested RMB 68.83 million in R&D, representing 5.18% of its revenue, which is an increase from 5.04% in the previous year [22]. - The company has developed new products and technologies, including high-performance copper alloys for liquid rocket engines and components [22][24]. - The R&D team, led by nine core technical personnel, has established partnerships with aerospace institutions to enhance technological capabilities [11][22]. Group 5: Market Risks and Challenges - The company faces risks related to technological advancements in the new materials industry, which require continuous R&D investment to maintain competitive advantages [10][17]. - Potential market disruptions may arise from the introduction of new materials and technologies that could replace existing products [17][18]. - The company is also exposed to risks from fluctuations in raw material prices, particularly copper, which significantly impacts production costs [14][16].
斯瑞新材(688102):铜基合金细分领域龙头,航天+医疗+半导体板块共振放量可期
Hua Yuan Zheng Quan· 2025-04-11 11:05
Investment Rating - The report assigns an "Accumulate" rating for the company, marking its first coverage [6]. Core Views - The company is a leader in the copper alloy segment, with expected growth driven by aerospace, medical, and semiconductor sectors [6][8]. - The company has shown steady growth in historical performance, with a projected revenue increase of 12.78% year-on-year for 2024, reaching 1.33 billion yuan [8][10]. - The company is actively expanding its production capacity and product offerings, which is anticipated to lead to accelerated revenue growth [11][42]. Summary by Sections 1. Company Overview - The company, established in 1995, has developed into a leader in high-strength and high-conductivity copper alloys and medium-high voltage contact materials, with a strong market position and recognition for its products [21][27]. 2. Financial Performance - From 2020 to 2023, the company's revenue and net profit have grown at a CAGR of 20.11% and 23.58%, respectively [8]. - For 2024, the company expects to achieve a revenue of 1.33 billion yuan and a net profit of 117 million yuan, reflecting year-on-year growth rates of 12.78% and 19.21% [10][11]. 3. Traditional Business Strengths - The company benefits from a strong position in traditional business areas, including traction motor end rings and high-end connector contacts, which are expected to see increased demand due to infrastructure projects [9][13]. - The company is the global leader in medium-high voltage contact materials, addressing domestic needs and exporting to international markets [33]. 4. Emerging Business Segments - The company is making significant progress in emerging sectors such as aerospace and medical imaging, with new products expected to contribute to revenue growth [4][14]. - Projects like the liquid rocket engine thrust chamber and CT/DR tube components are set to benefit from increasing market demand and production capacity expansions [15][39]. 5. Profit Forecast and Valuation - The company is projected to achieve net profits of 1.17 million yuan in 2024, 1.56 million yuan in 2025, and 2.10 million yuan in 2026, with respective growth rates of 19.21%, 33.44%, and 33.94% [10][11]. - The estimated P/E ratios for 2024, 2025, and 2026 are 74.27, 55.66, and 41.55, respectively, indicating a favorable valuation outlook [11].
斯瑞新材: 海通证券股份有限公司关于陕西斯瑞新材料股份有限公司向特定对象发行A股股票之发行保荐书
Zheng Quan Zhi Xing· 2025-04-03 11:46
Core Viewpoint - Shaanxi Sirui Advanced Materials Co., Ltd. is planning to issue A-shares to specific investors, with the total fundraising amount not exceeding 600 million yuan, aimed at supporting various projects including the industrialization of liquid rocket engine components and the construction of a technology industrial park [1][11]. Section 1: Basic Information of the Securities Issuance - The lead underwriter for the issuance is Haitong Securities Co., Ltd. [1] - The designated representatives for the project are Lin Wenting and Zhao Zhongtang, both experienced in investment banking [2][3]. - The project coordinator is Chen Qiuyue, who has participated in several IPO projects [3]. Section 2: Issuer Information - Shaanxi Sirui Advanced Materials Co., Ltd. was established on July 11, 1995, and became a joint-stock company on December 30, 2015, with a registered capital of 727,337,890 yuan [4]. - The company is listed on the Shanghai Stock Exchange under the stock code 688102 [4]. Section 3: Financial Data - As of September 30, 2024, the total assets of the company amounted to 200,822.78 million yuan, with total liabilities of 89,195.92 million yuan, resulting in total equity of 111,626.86 million yuan [5]. - For the first nine months of 2024, the company reported operating income of 96,430.81 million yuan and a net profit of 7,925.46 million yuan [5]. Section 4: Issuance Details - The type of shares to be issued is RMB ordinary shares (A-shares) with a par value of 1.00 yuan per share [7]. - The issuance will be directed towards no more than 35 specific investors, including various financial institutions and qualified individual investors [8]. - The pricing will be based on the average trading price of the company's shares over the 20 trading days prior to the issuance date, with a minimum price set at 80% of this average [8][9]. Section 5: Use of Proceeds - The proceeds from the issuance will be allocated to projects including the industrialization of liquid rocket engine components and the production of medical imaging equipment, with a total investment of 69,000 million yuan planned for these projects [11][19]. Section 6: Compliance and Approval - The issuance has undergone necessary internal reviews and has been approved by the board of directors and shareholders, complying with relevant laws and regulations [17][18]. - The company assures that the fundraising aligns with national industrial policies and will contribute to the development of the commercial aerospace sector [19][20].